【International Genomic Medicine Symposium – Patient Voices & Perspectives】   Science and empathy go hand in hand. 🧬✨   The Symposium spotlighted patient voices and community perspectives. Ms Alexandra Heumber Perry, then Chief Executive Officer of RARE DISEASES INTERNATIONAL, shared global patient insights and underscored the importance of equitable access and international collaboration to ensure that scientific advances translate into meaningful real-world impact. 💬🌍   📌 Patient Voices & Perspectives 🗣️ Speaker: Ms Alexandra Heumber Perry Then Chief Executive Officer, Rare Diseases International   🎥 Watch the full session: https://lnkd.in/g7JArBhT   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|InternationalGenomicMedicineSymposium} {hashtag|\#|PatientVoices} {hashtag|\#|RareDiseases} {hashtag|\#|GlobalHealth} {hashtag|\#|RDI}

【🎉 Celebrating 6 Years of HKGI: Advancing Genomic Medicine in Hong Kong 🎉】   Today, we proudly mark the 6th anniversary of HKGI — a milestone that reflects our shared commitment to advancing genomic medicine and improving health outcomes for the community.   Over the years, HKGI has made significant strides in building a strong foundation for precision medicine in Hong Kong.   🔬 Expanding the Hong Kong Genome Project (HKGP) We have successfully recruited over 60,000 participants across 12 public hospitals, accelerating the integration of genomics into clinical care and research. The HKGP has also achieved a diagnostic yield of 25% in identifying pathogenic variants for cases of undiagnosed disorders.  🤝 Nurturing Talent and Empowering the Community We have actively nurtured talent through targeted engagement initiatives for healthcare professionals, researchers, students and the public. These efforts have not only enhanced genomic literacy and clinical capabilities but also fostered greater community awareness and understanding of genomic medicine.   Our progress is made possible by the dedication of our partners, collaborators, and participants, who share our vision for the future of healthcare.   Looking ahead, HKGI will continue to integrate genomic medicine into clinical care, advance research, nurture talent, and strengthen public genomic literacy and industry partnerships — shaping a healthier future for Hong Kong and beyond, together.   💚 Thank you for being part of our journey.   {hashtag|\#|HKGI} {hashtag|\#|HKGP} {hashtag|\#|HongKongGenomeProject} {hashtag|\#|GenomicMedicine} {hashtag|\#|PrecisionMedicine} {hashtag|\#|HealthcareInnovation} {hashtag|\#|HKGIAnniversary}

【International Genomic Medicine Symposium - Panel 1】   At the International Genomic Medicine Symposium, experts from around the world came together to share perspectives on how genomic medicine continues to shape clinical practice.   Panel 1 explored how advances in understanding molecular pathogeneses are translating into better patient care. Prof Kym Boycott shared insights from her work in rare diseases, highlighting how advances at the molecular level translate into tangible benefits for patients and their families. ⭐ 💬 Session Chairperson: Dr Ronald Lam, JP Director of Health, Hong Kong SAR Government Hong Kong, China 📌Topic 1: Unraveling Molecular Pathogeneses to Enhance Patient Care and Family Well‑being 🗣️ Speaker: Prof Kym Boycott Co‑Chair, Lancet Commission on Rare Diseases Professor of Pediatrics, University of Ottawa Canada   🎥 Watch the full panel discussion: https://lnkd.in/gUxWWCzr Stay tuned for more panel highlights. 💡   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|GenomeProject} {hashtag|\#|PrecisionMedicine} {hashtag|\#|RareDiseases} {hashtag|\#|InternationalGenomicMedicineSymposium}

【International Genomic Medicine Symposium – Event Highlights】   We are pleased to share a highlight video from the International Genomic Medicine Symposium, jointly hosted by the Hong Kong Genome Institute (HKGI), RARE DISEASES INTERNATIONAL (RDI), and RDI-Lancet Commission on Rare Diseases (LCRD).   The symposium brought together leading experts from around the world for an inspiring exchange on the future of genomic medicine and rare disease research. 🧬🌍   🎥 Watch the highlight video: https://lnkd.in/gVPerzjQ   Thank you to all speakers, partners and participants for contributing to this impactful event. We remain committed to advancing international collaboration in genomic research and driving innovation to improve health outcomes. ✨   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|GenomeProject} {hashtag|\#|GlobalHealth} {hashtag|\#|RareDiseases} {hashtag|\#|PrecisionMedicine} {hashtag|\#|HealthcareInnovation}

【International Genomic Medicine Symposium - Panel 2】   From global perspectives to local clinical experience, Panel 2 of the International Genomic Medicine Symposium turned the spotlight on how genomic insights are being applied across healthcare settings.   Drawing on international expertise and HKGP case sharing, the discussion explored how genomics supports earlier diagnosis, targeted treatments, and personalised care. Prof Roberto Giugliani, Dr Derek Lee, and Dr Becky Ma shared practical insights from their work in rare diseases, cardiology, and nephrology. ⭐   💬 Session Chairperson: Dr Libby Lee, JP Chief Executive, Hospital Authority Hong Kong, China   📌 Topic 1: Insights into Rare Diseases: Focus on Inborn Errors of Metabolism 🗣️ Speaker: Prof Roberto Giugliani Co‑Chair, Lancet Commission on Rare Diseases Professor of Genetics, Federal University of Rio Grande do Sul Brazil   📌 Topic 2: Hong Kong Genome Project Case Sharing (1) — Unlocking the Genomics of Cardiomyopathy: A New Era in Heart Health 🗣️ Speaker: Dr Derek Lee Hong Kong College of Physicians – Hong Kong Genome Institute Scholar Hong Kong, China   📌 Topic 3: Hong Kong Genome Project Case Sharing (2) — Precision Medicine in Nephrology 🗣️ Speaker: Dr Becky Ma Hong Kong Academy of Medicine – Hong Kong Genome Institute Scholar Hong Kong, China   🎥 Watch the full panel discussion: https://lnkd.in/ggUwHJFm   Stay tuned for more panel highlights. 💡   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|GenomeProject} {hashtag|\#|PrecisionMedicine} {hashtag|\#|RareDiseases} {hashtag|\#|InternationalGenomicMedicineSymposium} {hashtag|\#|HongKongGenomeProject}

【HKGI Joins GA4GH NIF 🌏 Advancing Global Genomic Collaboration】   We are pleased to share that HKGI has officially joined the Global Alliance for Genomics and Health (GA4GH) as a member of the National Initiatives Forum (NIF). 🎉   As part of this prestigious forum, we join national genomics programmes worldwide in sharing best practices, promoting the adoption of global standards, and supporting responsible genomic data sharing at scale. Through this collaboration, we will implement GA4GH standards globally and promote compatibility of clinical and research genomic data to advance genomic medicine and improve health outcomes.    We look forward to strengthening both local and international collaborations as we collectively advance the future of precision healthcare. 🤝   Learn more about the NIF and its membership: https://lnkd.in/gyj-nkPa   {hashtag|\#|HKGI} {hashtag|\#|HKGP} {hashtag|\#|GenomicMedicine} {hashtag|\#|GA4GH} {hashtag|\#|PrecisionMedicine} {hashtag|\#|GlobalCollaboration}